PCA analysis recapitulated these differences, highlighting CD193, CD66b, CD11a, CD24, CXCR4, and CD62L as the most affected parameters in eosinophils from COVID-19 patients (Fig. 4D). This evidence concerns the gene CEACAM8 and COVID-19.